PL371102A1 - Bezpostaciowa forma o wymaganym wymiarze cząstek inhibitorów reduktazy HMG-CoA - Google Patents

Bezpostaciowa forma o wymaganym wymiarze cząstek inhibitorów reduktazy HMG-CoA

Info

Publication number: PL371102A1
Authority: PL; Poland
Prior art keywords: particle size; coa reductase; desired particle; reductase inhibitors; amorphous hmg
Prior art date: 2002-03-18

Application number

PL02371102A

Other languages

English (en)

Other versions

PL208890B1 (pl

Inventor

Acharya Poornaprajna

Joy Mathew

Ravindra Chandrappa

Madhavan Sridharan

Sambasivam Ganesh

Original Assignee

Biocon Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-18

Filing date

2002-03-18

Publication date

2005-06-13

2002-03-18 Application filed by Biocon Limited filed Critical Biocon Limited

2002-03-18 Priority to PL371102A priority Critical patent/PL208890B1/pl

2005-06-13 Publication of PL371102A1 publication Critical patent/PL371102A1/pl

2011-06-30 Publication of PL208890B1 publication Critical patent/PL208890B1/pl

Links

229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
239000002245 particle Substances 0.000 title 1
229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title 1

PL371102A 2002-03-18 2002-03-18 Sposób wytwarzania bezpostaciowej formy atorwastatyny i prowastatyny jako inhibitorów reduktazy HMG-CoA PL208890B1 (pl)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
PL371102A PL208890B1 (pl)	2002-03-18	2002-03-18	Sposób wytwarzania bezpostaciowej formy atorwastatyny i prowastatyny jako inhibitorów reduktazy HMG-CoA

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PL371102A PL208890B1 (pl)	2002-03-18	2002-03-18	Sposób wytwarzania bezpostaciowej formy atorwastatyny i prowastatyny jako inhibitorów reduktazy HMG-CoA

Publications (2)

Publication Number	Publication Date
PL371102A1 true PL371102A1 (pl)	2005-06-13
PL208890B1 PL208890B1 (pl)	2011-06-30

Family

ID=35768811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL371102A PL208890B1 (pl)	2002-03-18	2002-03-18	Sposób wytwarzania bezpostaciowej formy atorwastatyny i prowastatyny jako inhibitorów reduktazy HMG-CoA

Country Status (1)

Country	Link
PL (1)	PL208890B1 (pl)

2002
- 2002-03-18 PL PL371102A patent/PL208890B1/pl not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL208890B1 (pl)	2011-06-30

Similar Documents

Publication	Publication Date	Title
EP1684754A4 (en)	2010-05-12	HMG COA REDUCTASE INHIBITORS AND METHOD
AU2003281324A1 (en)	2004-01-23	Antisense modulation of hmg-coa reductase expression
PL375389A1 (pl)	2005-11-28	Nowe inhibitory kinaz
PL359820A1 (pl)	2004-09-06	Inhibitory reduktazy HMG-CoA i sposób leczenia
AU2003259749A1 (en)	2004-02-25	3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003255376A1 (en)	2004-03-11	Piperidine-derivatives as pde4 inhibitors
AU2003265395A1 (en)	2004-03-03	Prenylation inhibitors and methods of their synthesis and use
AU2003251559A1 (en)	2004-01-06	Heterocyclic inhibitors of kinases
EP1549316A4 (en)	2008-04-09	HAMMER OF TFGbeta
IL169090A0 (en)	2007-07-04	Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
AU2003303128A1 (en)	2004-08-13	Inhibitors and methods of use thereof
AU2003243603A1 (en)	2003-12-31	Methods and compositions involving aldose reductase inhibitors
IL159588A0 (en)	2004-06-01	Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
AU2003217105A1 (en)	2003-09-16	Novel of cytokine inhibitors
AU2003250172A1 (en)	2004-02-16	Compositions comprising hmg-coa reductase inhibitor
IL165475A0 (en)	2006-01-15	Nitrooxyderivatives of eyclooxygenase-2 inhibitors
PL371217A1 (pl)	2005-06-13	Inhibitory integryny alfaVbeta6
PL374581A1 (pl)	2005-10-31	Diaminotiazole przydatne jako selektywne inhibitory CDK4
AU2003270154A1 (en)	2004-04-30	Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
HUP0500074A3 (en)	2005-07-28	Amorphous hmg-coa reductase inhibitors of desired particle size and process for producing them
AU2003302588A1 (en)	2004-06-23	Phosphodiesterase 10a inhibitors
AU2003236636A1 (en)	2003-11-11	COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER
AU2003256323A1 (en)	2004-01-19	Sos1 inhibitors
EP1812019A4 (en)	2007-12-26	COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERLIPIDEMIA
IL157597A0 (en)	2004-03-28	Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors

Legal Events

Date	Code	Title	Description
2012-01-31	RECP	Rectifications of patent specification
2014-04-30	LAPS	Decisions on the lapse of the protection rights	Effective date: 20130318